Literature DB >> 25711668

Evaluation of an automated surveillance system using trigger alerts to prevent adverse drug events in the intensive care unit and general ward.

John P DiPoto1, Mitchell S Buckley, Sandra L Kane-Gill.   

Abstract

INTRODUCTION: Adverse events in the intensive care unit (ICU) may be associated with several possible causes, so determining a drug-related causal assessment is more challenging than in general ward patients. Therefore, the hypothesis was that automated trigger alerts may perform differently in various patient care settings. The purpose of this study was to compare the frequency and type of clinically significant automated trigger alerts in critically ill and general ward patients as well as evaluate the performance of alerts for drug-related hazardous conditions (DRHCs).
METHODS: A retrospective cohort study was conducted in adult ICU and general ward patients at three institutions (academic, community, and rural hospital) in a health system. Automated trigger alerts generated during two nonconsecutive months were obtained from a centralized database. Pharmacist responses to alerts and prescriber response to recommendations were evaluated for all alerts. A clinical significant event was defined as an actionable intervention requiring drug therapy changes that the pharmacist determined to be appropriate for patient safety and where the physician accepted the pharmacist's recommendation. The positive predictive value (PPV) was calculated for each trigger alert considered a DRHC (i.e., abnormal laboratory values and suspected drug causes).
RESULTS: A total of 751 alerts were generated in 623 patients during the study period. Pharmacists intervened on 39.8 and 44.8 % alerts generated in the ICU and general ward, respectively. Overall, the physician acceptance rate of approximately 90 % was comparable irrespective of patient care setting. Therefore, the number of clinically significant alerts was 88.9 and 83.4 % for the ICU and non-ICU, respectively. The types of drug therapy changes were similar between settings. The PPV of alerts identifying a DRHC was 0.66 in the ICU and 0.76 in general ward patients.
CONCLUSIONS: The number and type of clinically significant alerts were similar irrespective of patient population, suggesting that the alerts may be equally as beneficial in the ICU population, despite the challenges in drug-related event adjudication. An opportunity exists to improve the performance of alerts in both settings, so quality improvement programs for measuring alert performance and making refinements is needed.

Entities:  

Mesh:

Year:  2015        PMID: 25711668     DOI: 10.1007/s40264-015-0272-1

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  28 in total

1.  A comparison of voluntarily reported medication errors in intensive care and general care units.

Authors:  S L Kane-Gill; J G Kowiatek; R J Weber
Journal:  Qual Saf Health Care       Date:  2010-02

2.  Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

Authors:  A K Jha; G J Kuperman; J M Teich; L Leape; B Shea; E Rittenberg; E Burdick; D L Seger; M Vander Vliet; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

3.  A trigger tool to identify adverse events in the intensive care unit.

Authors:  Roger K Resar; John D Rozich; Terri Simmonds; Carol R Haraden
Journal:  Jt Comm J Qual Patient Saf       Date:  2006-10

4.  Analysis of risk factors for adverse drug events in critically ill patients*.

Authors:  Sandra L Kane-Gill; Levent Kirisci; Margaret M Verrico; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

5.  The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care.

Authors:  Jeffrey M Rothschild; Christopher P Landrigan; John W Cronin; Rainu Kaushal; Steven W Lockley; Elisabeth Burdick; Peter H Stone; Craig M Lilly; Joel T Katz; Charles A Czeisler; David W Bates
Journal:  Crit Care Med       Date:  2005-08       Impact factor: 7.598

6.  Computerized detection of adverse drug reactions in the medical intensive care unit.

Authors:  Sandra L Kane-Gill; Shyam Visweswaran; Melissa I Saul; An-Kwok Ian Wong; Louis E Penrod; Steven M Handler
Journal:  Int J Med Inform       Date:  2011-05-31       Impact factor: 4.046

7.  Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection.

Authors:  Brian J Kopp; Brian L Erstad; Michelle E Allen; Andreas A Theodorou; Gail Priestley
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

8.  Preventing adverse drug events in hospitalized patients.

Authors:  R S Evans; S L Pestotnik; D C Classen; S D Horn; S B Bass; J P Burke
Journal:  Ann Pharmacother       Date:  1994-04       Impact factor: 3.154

9.  Adverse drug events and medication errors: detection and classification methods.

Authors:  T Morimoto; T K Gandhi; A C Seger; T C Hsieh; D W Bates
Journal:  Qual Saf Health Care       Date:  2004-08

10.  Analysis of electronic medication orders with large overdoses: opportunities for mitigating dosing errors.

Authors:  E S Kirkendall; M Kouril; T Minich; S A Spooner
Journal:  Appl Clin Inform       Date:  2014-01-08       Impact factor: 2.342

View more
  11 in total

1.  Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.

Authors:  Daniel Sevilla-Sanchez; Núria Molist-Brunet; Jordi Amblàs-Novellas; Pere Roura-Poch; Joan Espaulella-Panicot; Carles Codina-Jané
Journal:  Eur J Clin Pharmacol       Date:  2016-10-04       Impact factor: 2.953

2.  Association between neonatal intensive care unit medication safety practices, adverse events, and death.

Authors:  Laura E Miller; Chris DeRienzo; P Brian Smith; Carl Bose; Reese H Clark; C Michael Cotten; Daniel K Benjamin; Chi D Hornik; Rachel G Greenberg
Journal:  J Perinatol       Date:  2020-10-08       Impact factor: 2.521

3.  Evaluation of accuracy of IHI Trigger Tool in identifying adverse drug events: a prospective observational study.

Authors:  Maria das Dores Graciano Silva; Maria Auxiliadora Parreiras Martins; Luciana de Gouvêa Viana; Luiz Guilherme Passaglia; Renata Rezende de Menezes; João Antonio de Queiroz Oliveira; Jose Luiz Padilha da Silva; Antonio Luiz Pinho Ribeiro
Journal:  Br J Clin Pharmacol       Date:  2018-07-08       Impact factor: 4.335

4.  Effect of Best Practice Advisories on Sedation Protocol Compliance and Drug-Related Hazardous Condition Mitigation Among Critical Care Patients.

Authors:  Rebecca A Greene; Andrew R Zullo; Craig M Mailloux; Christine Berard-Collins; Mitchell M Levy; Timothy Amass
Journal:  Crit Care Med       Date:  2020-02       Impact factor: 7.598

5.  Trigger alerts associated with laboratory abnormalities on identifying potentially preventable adverse drug events in the intensive care unit and general ward.

Authors:  Mitchell S Buckley; Jeffrey R Rasmussen; Dale S Bikin; Emily C Richards; Andrew J Berry; Mark A Culver; Ryan M Rivosecchi; Sandra L Kane-Gill
Journal:  Ther Adv Drug Saf       Date:  2018-03-01

Review 6.  Clinical decision support for drug related events: Moving towards better prevention.

Authors:  Sandra L Kane-Gill; Archita Achanta; John A Kellum; Steven M Handler
Journal:  World J Crit Care Med       Date:  2016-11-04

7.  Leveraging Food and Drug Administration Adverse Event Reports for the Automated Monitoring of Electronic Health Records in a Pediatric Hospital.

Authors:  Huaxiu Tang; Imre Solti; Eric Kirkendall; Haijun Zhai; Todd Lingren; Jaroslaw Meller; Yizhao Ni
Journal:  Biomed Inform Insights       Date:  2017-06-08

8.  Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?

Authors:  Grazielle Viana Ramos; André Miguel Japiassú; Fernando Augusto Bozza; Lusiele Guaraldo
Journal:  Clinics (Sao Paulo)       Date:  2018-02-19       Impact factor: 2.365

9.  Clinical pharmacist intervention reduces mortality in patients with acute myocardial infarction: a propensity score matched analysis.

Authors:  Xiao-Bo Zhai; Zhi-Chun Gu; Xiao-Yan Liu
Journal:  Eur J Hosp Pharm       Date:  2018-03-14

10.  Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysis.

Authors:  Xiao-Bo Zhai; Zhi-Chun Gu; Xiao-Yan Liu
Journal:  Ther Clin Risk Manag       Date:  2016-02-18       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.